#USA #New York #Investor Rights #Rosen Law Firm #LifeMD

LifeMD Securities Fraud Lawsuit: What Investors Need to Know

In a significant legal development, the Rosen Law Firm has called attention to investors who purchased securities of LifeMD, Inc. (NASDAQ: LFMD) during the period from May 7, 2025, to August 5, 2025. As the deadline for potential lead plaintiffs approaches on October 27, 2025, affected purchasers are encouraged to consider their options regarding a securities fraud class action lawsuit.

Overview of the Legal Action

The lawsuit alleges that during the specified class period, the defendants made materially false and misleading statements about LifeMD's financial standing and business operations. Investors are now reminded that if they acquired shares of LifeMD during this timeframe, they could be entitled to compensation without any upfront costs, thanks to a contingency fee arrangement with the law firm.

Lead Plaintiff Role

It's essential for potential claimants to understand the lead plaintiff's role in class actions. A lead plaintiff acts on behalf of all class members, guiding the litigation process. To take on this role, an investor must file a motion in court no later than October 27, 2025. Should an individual wish to join the action, they are advised to visit the Rosen Law Firm's website or contact attorney Phillip Kim directly for further instructions.

Allegations Against LifeMD

According to the complaint, the investors have alleged that the defendants significantly overstated LifeMD's competitive position and misrepresented the company's ability to manage its acquisition costs effectively. Particularly concerning were claims made regarding their RexMD segment and the associated costs of drugs aimed at treating obesity, such as Wegovy and Zepbound. These misleading representations led to a false perception of LifeMD's operational success and market position during the class period. When the reality became evident, investors experienced financial losses.

Importance of Choosing the Right Counsel

The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel, especially for prospective plaintiffs in securities class actions. Many firms may lack experience or resources compared to others like Rosen Law Firm, which has a strong track record of successful litigations in this area. Notably, the firm has achieved substantial settlements for investors in the past, with over $438 million secured in 2019 alone.

How to Participate in the Class Action

For investors wishing to join the class action, Rosen Law Firm provides a straightforward process. Interested parties can fill out a submission form on their website, or reach out to Phillip Kim at 866-767-3653 or via email at [email protected].

Stay Informed

Investors are encouraged to keep abreast of updates on this class action. They can follow Rosen Law Firm on their LinkedIn, Twitter, or Facebook to stay informed about the lawsuit and other related developments.

Conclusion

As the deadline approaches, affected investors should consider their options carefully. The opportunity to lead a class action not only holds the potential for financial recovery but also for holding accountable those responsible for any misleading practices. With the right legal support, this process may offer significant benefits to those impacted by the alleged securities fraud.

• ---

This article aims to inform LifeMD investors of their rights and available actions in the wake of the recent securities fraud lawsuit initiated by Rosen Law Firm. For those considering participation, seeking qualified legal counsel is essential for navigating the complexities of securities class actions.